4
Changes in Ownership
Annexon, Inc. Filed Acc 0001567619-21-017166
EVP & Chief Scientific Officer sold 16,190 shares at $20.00 ($323,860)
- EVP & Chief Scientific Officer acquired 16,190 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yednock Ted EVP & Chief Scientific Officer | 2021-09-13 | Option exercise | +15,000 | $1.41 | $21,144 | 15,000 | D: show line 1 in the form |
| Yednock Ted EVP & Chief Scientific Officer | 2021-09-13 | Option exercise | +1,190 | $5.11 | $6,081 | 16,190 | D: show line 2 in the form |
| Yednock Ted EVP & Chief Scientific Officer | 2021-09-13 | Sale | −16,190 | $20.00 | $323,860 | 0 | D: show line 3 in the form |
| Open-market sales · 16,190 sh · avg $20.00 · $323,860 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yednock Ted EVP & Chief Scientific Officer | 2021-09-13 | Option exercise · Stock Option (Right to Buy) | −15,000 | 10,615 | D: show line 4 in the form | ||
| Yednock Ted EVP & Chief Scientific Officer | 2021-09-13 | Option exercise · Stock Option (Right to Buy) | −1,190 | 67,939 | D: show line 5 in the form |
Loading xslF345X03/doc1.xml…